Q1 2024 revenue increased 74% over Q1 2023 to $73 million
Q1 2024 total test reports increased 40% over Q1 2023
Raising full-year 2024 revenue guidance to $255-265 million from $235-240.
Castle Biosciences Reports First Quarter 2024 Results wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Expect to deliver 2023 total revenue of more than $210 million, at least 53% growth over 2022
Delivered 70,429 total test reports in 2023, an increase of 59% compared to 2022
Year-end 2023 cash,.